Drug Shortage Report for AURO-LOSARTAN HCT
| Report ID | 97195 |
| Drug Identification Number | 02423650 |
| Brand name | AURO-LOSARTAN HCT |
| Common or Proper name | Hydrochlorothiazide; Losartan Potassium |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
| Strength(s) | 12.5MG 100MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 & 100 |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2019-10-23 |
| Estimated end date | 2021-07-14 |
| Actual end date | 2021-05-20 |
| Shortage status | Resolved |
| Updated date | 2021-07-12 |
| Company comments | Auro-Losartan HCT 100/12.5mg Tab 100 Btl is available. Auro-Losartan HCT 100/12.5mg Tab (30's) Btl is discontinued |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.